Antiarrhythmic effects of the thromboxane antagonist BM 13.177

This publication has 17 references indexed in Scilit:

• Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion
  Journal of Molecular and Cellular Cardiology, 1987
• Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion
  American Heart Journal, 1986
• Further evidence that thromboxane exacerbates arrhythmias: Effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds
  Journal of Molecular and Cellular Cardiology, 1984
• Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease
  The American Journal of Cardiology, 1984
• Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets
  Thrombosis Research, 1984
• The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds
  Journal of Molecular and Cellular Cardiology, 1984
• Prostacyclin—Antiarrhythmic or Arrhythmogenic? Comparison of the Effects of Intravenous and Intracoronary Prostacyclin and ZK36374 During Coronary Artery Occlusion and Reperfusion in Anaesthetised Greyhounds
  Journal of Cardiovascular Pharmacology, 1983
• The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs.
  Circulation Research, 1983
• Thromboxane and prostacyclin in systemic and coronary vascular beds following endoperoxide analog infusion
  The American Journal of Cardiology, 1982
• Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
  New England Journal of Medicine, 1979